Clovis Oncology, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-06-12: Reporting owner BLAIR JAMES C; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-12: Reporting owner KLINGENSTEIN PAUL H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-12: Reporting owner BARRETT M JAMES; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-12: Reporting owner GRAHAM GINGER L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-06-12 | BLAIR JAMES C Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-19 | |
| 2014-06-12 | KLINGENSTEIN PAUL H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | BARRETT M JAMES Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | GRAHAM GINGER L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | Flaherty Keith T. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | SPICKSCHEN THORLEF Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | ATWOOD BRIAN G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-06-12 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $44.52 exercise price | 2014-06-16 | |
| 2014-05-14 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,413 0 owned after | $11.02 exercise price | 2014-05-16 | |
| 2014-05-14 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,414 0 owned after | $19.46 exercise price | 2014-05-16 | |
| 2014-01-10 | Hoerter Steven L. Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $73.98 exercise price | 2014-01-14 | |
| 2014-01-10 | Allen Andrew R Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $73.98 exercise price | 2014-01-14 | |
| 2014-01-10 | IVERS-READ GILLIAN C Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $73.98 exercise price | 2014-01-14 | |
| 2014-01-10 | MAST ERLE T Officer (Executive VP and CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $73.98 exercise price | 2014-01-14 | |
| 2014-01-10 | MAHAFFY PATRICK J Director, Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $73.98 exercise price | 2014-01-14 |